Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (21)
COVID-19 (7)
Type
(
1 selected
)
Type
Guidance (2013)
NICE advice (319)
Quality standard (197)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (21)
Antimicrobial resistance guidance (2)
Cancer service guidelines (5)
Clinical guidelines (229)
COVID-19 rapid guidelines (8)
HealthTech guidance (765)
Highly specialised technologies guidance (30)
Medicines practice guidelines (5)
NICE guidelines (335)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (69)
Technology appraisal guidance (881)
Apply filters
Showing 1 to 25 of 2013
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites
TA1045
5 March 2025
5 March 2025
3C Patch for treating diabetic foot ulcers
HTG615
7 March 2022
7 March 2022
Ab externo canaloplasty for primary open-angle glaucoma
HTG448
13 September 2017
13 September 2017
Ab interno canaloplasty for open-angle glaucoma
HTG647
22 November 2022
22 November 2022
Abaloparatide for treating osteoporosis after menopause
TA991
7 August 2024
7 August 2024
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal)
TA568
13 March 2019
13 March 2019
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
TA373
16 December 2015
16 December 2015
Abdominal aortic aneurysm: diagnosis and management
NG156
19 March 2020
19 March 2020
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
TA563
27 February 2019
27 February 2019
Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence
TA810
20 July 2022
20 July 2022
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
TA725
15 September 2021
15 September 2021
Abiraterone (originator and generics) for treating newly diagnosed high-risk hormone‑sensitive metastatic prostate cancer
TA1110
19 November 2025
19 November 2025
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen
TA259
27 June 2012
27 July 2016
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
TA387
27 April 2016
27 July 2016
Abortion care
NG140
25 September 2019
27 May 2025
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis
TA814
3 August 2022
3 August 2022
Acalabrutinib for treating chronic lymphocytic leukaemia
TA689
21 April 2021
21 April 2021
Acne vulgaris: management
NG198
25 June 2021
7 December 2023
Acoramidis for treating transthyretin amyloidosis with cardiomyopathy
TA1121
14 January 2026
14 January 2026
Acute coronary syndromes
NG185
18 November 2020
18 November 2020
Acute heart failure: diagnosis and management
CG187
8 October 2014
17 November 2021
Acute kidney injury: prevention, detection and management
NG148
18 December 2019
16 October 2024
Acute upper gastrointestinal bleeding in over 16s: management
CG141
13 June 2012
25 August 2016
Acutely ill adults in hospital: recognising and responding to deterioration
CG50
25 July 2007
25 July 2007
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (terminated appraisal)
TA1076
2 July 2025
2 July 2025
Current page
1
2
3
…
81
Page
1
of
81
Next page
Results per page
10
25
50
All
Back to top